Dr. Peter Kecskemethy is a serial entrepreneur and the CEO and co-founder of Kheiron Medical, an AI cancer diagnostics company based in London. Kheiron’s mission is to give a better fighting chance against cancer and its current focus is breast screening. Prior to Kheiron, Peter founded two tech start-ups and was lead developer in two others. He is a computer scientist, and did his PhD and post-doctoral research at the University of Oxford in high performance computing and computational statistics for population genetics.